INS and metabolic disease: l-Arabinose supplementation was reported to regulate glucose homeostasis via inhibition of hepatic gluconeogenesis and improvement of insulin sensitivity, thus suppressing elevated plasma glucose and insulin levels in metabolic disorder mice [31].